Mediwound Ltd
NASDAQ:MDWD

Watchlist Manager
Mediwound Ltd Logo
Mediwound Ltd
NASDAQ:MDWD
Watchlist
Price: 21.96 USD 2.91% Market Closed
Market Cap: 237.4m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+14%
Revenue
Forecast
+23%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

MDWD Price Targets Summary
Mediwound Ltd

Wall Street analysts forecast MDWD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDWD is 30.6 USD with a low forecast of 25.25 USD and a high forecast of 40.95 USD.

MDWD Lowest Forecast
Wall Street Target
25.25 USD
15% Upside
MDWD Average Forecast
Wall Street Target
30.6 USD
39% Upside
MDWD Highest Forecast
Wall Street Target
40.95 USD
86% Upside
Lowest
Price Target
25.25 USD
15% Upside
Average
Price Target
30.6 USD
39% Upside
Highest
Price Target
40.95 USD
86% Upside
Mediwound Ltd Competitors:
Price Targets
LAURUSLABS
Laurus Labs Ltd
2% Downside
002422
Sichuan Kelun Pharmaceutical Co Ltd
12% Upside
S
2005
SSY Group Ltd
77% Upside
K
4521
Kaken Pharmaceutical Co Ltd
29% Upside
LAURUSLABS
Laurus Labs Ltd
2% Downside
002422
Sichuan Kelun Pharmaceutical Co Ltd
12% Upside
S
2005
SSY Group Ltd
77% Upside
K
4521
Kaken Pharmaceutical Co Ltd
29% Upside
1477
Ocumension Therapeutics
4% Downside
CAPLIPOINT
Caplin Point Laboratories Ltd
16% Upside
4530
Hisamitsu Pharmaceutical Co Inc
20% Upside
C
1093
CSPC Pharmaceutical Group Ltd
16% Downside

Revenue
Forecast

Revenue Estimate
Mediwound Ltd

For the last 8 years the compound annual growth rate for Mediwound Ltd's revenue is 38%. The projected CAGR for the next 3 years is 27%.

38%
Past Growth
27%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Mediwound Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Mediwound Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

See Also

Summary
MDWD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MDWD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MDWD stock valuation using valuation multiples.
Wall Street Estimates
MDWD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MDWD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDWD's stock price target?
Price Target
30.6 USD

According to Wall Street analysts, the average 1-year price target for MDWD is 30.6 USD with a low forecast of 25.25 USD and a high forecast of 40.95 USD.

What is Mediwound Ltd's Revenue forecast?
Projected CAGR
27%

For the last 8 years the compound annual growth rate for Mediwound Ltd's revenue is 38%. The projected CAGR for the next 3 years is 27%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.